Aktie ABB AB-BIOTICS, S.A.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen AB-Biotics, S.A.

Aktien

ABB

ES0109659013

ABB

Schlusskurs BME
Andere Börsenplätze
 		% 5 Tage % 1. Jan.
- EUR -.--% Intraday Chart für AB-Biotics, S.A. -.--% -.--%
2022 AB-Biotics, S.A. übernimmt Alifarm S.A. für 3,5 Millionen Euro. CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
AB-Biotics, S.A. acquired Alifarm S.A. for EUR 3.5 million.
Kaneka Europe Holding Company N.V. completed the acquisition of 18.21% stake in AB-Biotics, S.A.
Kaneka Europe Holding Company N.V. made an offer to acquire remaining 33.67% stake in AB-Biotics, S.A. for €21.2 million.
Kaneka Corporation has completed the voluntary offer to acquire an additional 26.57% stake in AB-Biotics, S.A. for €16.7 million.
Kaneka Corporation made a voluntary public offer to acquire the remaining 60.24% stake in AB-Biotics, S.A. for €37.9 million.
Ab-Biotics Sa Reports Earnings Results for the Full Year Ended December 31, 2018
Kaneka Corporation Concludes License Agreement with AB-Biotics for Production and Sales of its Probiotics Products
Kaneka Corporation completed the acquisition of 26.87% stake in AB-Biotics, S.A. from Corporacion Ivamosa, Gestion Y Administracion Mobiliaria, S.A., Capital MAB, FCR fund of Institut Català de Finances Capital, SGEIC, S.A. and Buanaventura Guamis.
Kaneka Americas Holding Inc. enters into Licensing Agreement with AB-Biotics, S.A
Kaneka Corporation signed an agreement to acquire 26.87% stake in AB-Biotics, S.A. from Corporacion Ivamosa, Gestion Y Administracion Mobiliaria, S.A., Capital MAB, FCR fund of Institut Català de Finances Capital, SGEIC, S.A. and Buanaventura Guamis.
Corporacion Ivamosa and Gestion Y Administracion Mobiliaria, S.A. acquired 10% stake in AB-Biotics, S.A..
Frutarom Industries Ltd. acquired AB-Fortis from AB-Biotics, S.A..
AB-Biotics SA announced a financing transaction
AB-Biotics Agrees Distribution Deal with Abbott for I3.1 Probiotic in Spain
DuPont Nutrition & Health and AB-Biotics Announce Agreement on Probiotic for Cardiovascular Health
AB-Biotics Provides Earnings Guidance for the Full Year of 2013
AB-Biotics SA sold Quantum Experimental S.L.
AB-Biotics and Scienta Farma Sign Distribution Agreement to Market Genetic Test Neurofarmagen in Mexico
AB-Biotics SA announced that it expects to receive €1.08 million in funding.
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. ABB Aktie
  4. Nachrichten AB-Biotics, S.A.
  5. Andere Sprachen